Inpharmica Overview
- Year Founded
-
2011
- Status
-
Private
- Latest Deal Type
-
Liquidation
Inpharmica General Information
Description
Developer of a bio-medicine technology designed to aid complex painkiller drug development. The company's technology is used in clinical studies on an increased number of patients, including the monitoring of undesired effects and the development of documentation to register a new complex painkiller patented, enabling patients to access next-generation painkillers.
Contact Information
Corporate Office
- Obrzezna 18/31
- Warsaw, Mazowieckie 02-691
- Poland
Corporate Office
- Obrzezna 18/31
- Warsaw, Mazowieckie 02-691
- Poland
Inpharmica Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Bankruptcy: Liquidation | 18-Mar-2021 | Completed | Bankruptcy: Liquidation | |||
| 1. Seed Round | 18-Dec-2015 | Completed | Clinical Trials - Phase 3 |
Inpharmica Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Inpharmica FAQs
-
When was Inpharmica founded?
Inpharmica was founded in 2011.
-
Where is Inpharmica headquartered?
Inpharmica is headquartered in Warsaw, Poland.
-
What industry is Inpharmica in?
Inpharmica’s primary industry is Drug Discovery.
-
Is Inpharmica a private or public company?
Inpharmica is a Private company.
-
What is Inpharmica’s current revenue?
The current revenue for Inpharmica is .
-
How much funding has Inpharmica raised over time?
Inpharmica has raised $356K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
